Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Prospective phase 2a clinical trial to demonstrate proof-of-concept for simultaneous
hyperpolarized [1-13C]pyruvate and 18F-FDG for positron emission tomography (PET) and MRS
(magnetic resonance spectroscopy) in a PET/MR scanner in patients with cancer.